[Specialization in veterinary medicine].

E. Teske

1993-09-15

Abstract:

What problem does this paper attempt to address?

Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report

Sandeep Kumar,Rohit Bansal,Priya Bansal,Rajinder Kumar Dhamija,Dnb Neurology

DOI: https://doi.org/10.7812/TPP/19.088

Abstract:Introduction: Drug-induced immune hemolytic anemia (DIIHA) is a rare complication of any drug therapy, which if not recognized early can be fatal. It is usually underdiagnosed. Ceftriaxone is a commonly used antibiotic in routine practice and is one of the most common drugs to cause DIIHA. Case presentation: We report a case of ceftriaxone-induced immune hemolytic anemia in a 62-year-old woman who had a negative result of a direct antiglobulin test. Discussion: A review of the literature highlights the salient features of DIIHA and underscores the importance of keeping the suspicion of DIIHA high in the relevant clinical settings because ceftriaxone has been associated with particularly severe outcomes of DIIHA. In cases of unclear hemolysis and despite a negative result of a direct antiglobulin test, the treating physician must keep suspicion of DIIHA high and meticulously look for the possible culprit drugs. Treatment with suspected drugs must be stopped promptly to prevent severe complications and fatal outcomes.
Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature

Hans Benno Leicht,Elke Weinig,Beate Mayer,Johannes Viebahn,Andreas Geier,Monika Rau

DOI: https://doi.org/10.1186/s40360-018-0257-7

2018-10-25

Abstract:Background: Drug induced immune hemolytic anemia (DIIHA) is a rare complication and often underdiagnosed. DIIHA is frequently associated with a bad outcome, including organ failure and even death. For the last decades, ceftriaxone has been one of the most common drugs causing DIIHA, and ceftriaxone-induced immune hemolytic anemia (IHA) has especially been reported to cause severe complications and fatal outcomes. Case presentation: A 76-year-old male patient was treated with ceftriaxone for cholangitis. Short time after antibiotic exposure the patient was referred to intensive care unit due to cardiopulmonary instability. Hemolysis was observed on laboratory testing and the patient developed severe renal failure with a need for hemodialysis for 2 weeks. Medical history revealed that the patient had been previously exposed to ceftriaxone less than 3 weeks before with subsequent hemolytic reaction. Further causes for hemolytic anemia were excluded and drug-induced immune hemolytic (DIIHA) anemia to ceftriaxone could be confirmed. Conclusions: The case demonstrates the severity of ceftriaxone-induced immune hemolytic anemia, a rare, but immediately life-threatening condition of a frequently used antibiotic in clinical practice. Early and correct diagnosis of DIIHA is crucial, as immediate withdrawal of the causative drug is essential for the patient prognosis. Thus, awareness for this complication must be raised among treating physicians.
Simulation model for wide-area multi-service passive radar coverage predictions

W. Barott,B. Himed

DOI: https://doi.org/10.1109/RADAR.2013.6586131

2013-09-09

Abstract:This paper describes the simulation approach and model for a software tool used to analyze passive radar scenarios. A database of known transmitters includes more than 250,000 sources from FM radio, digital television, cellular, and aeronautical radio-navigation aids. Terrain is considered using digital elevation maps and the Irregular Terrain Model. The tool calculates the expected detection and localization performance for PBR receivers, and can be used to guide receiver design.
[Surgical repair of secondary local defect after auricular reconstruction].

Bo Pan,H. Zhuang,Zhen Cai

2007-12-01

Abstract:
Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis

Jun Yong,Freddy Frost,Dilip Nazareth,Martin Walshaw

DOI: https://doi.org/10.12688/f1000research.14505.1

2018-04-18

Abstract:Drug-induced Immune Haemolytic Anaemia (DIIHA) is a rare but serious complication of cephalosporin use. Ceftazidime is recognized to be a rare cause of DIIHA. We report and discuss a case of DIIHA in a person with cystic fibrosis who developed severe haemolytic anaemia following use of ceftazidime in the management of an acute pseudomonal pulmonary exacerbation.
Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness

James Tasch,Pedro Gonzalez-Zayaz

DOI: https://doi.org/10.12659/AJCR.903507

2017-04-21

Abstract:BACKGROUND Drug-induced immune hemolytic anemia (DIIHA) is a rare condition that may result from the administration of an antibiotic, most notably the cephalosporin class, commonly used in both the adult and pediatric populations. A delay in recognition by a provider may lead to continuation of the offending agent and possibly result in fatal outcomes. CASE REPORT We report the case of a 65-year-old woman on ceftriaxone infusions after being diagnosed with acute mitral valve endocarditis 3 weeks prior, which presented with severe anemia and bilateral transient vision loss. Being a Jehovah's Witness, the patient refused blood product transfusions and was managed with alternative therapies. The etiology of the symptoms was suspected to be a hemolytic anemia directly related to her ceftriaxone infusions. CONCLUSIONS This report demonstrates the importance of close vigilance while prescribing drugs known to cause hemolytic anemia. Although rare, drug-induced immune hemolytic anemia caused by ceftriaxone may be a potentially fatal condition, but with early recognition and withdrawal of the offending agent, successful treatment may ensue. Serological tests should be utilized to obtain a definitive diagnosis.
AD-A 201 35 0 Distribution Unlimited

T. Cebeci,Wenhan,Su

Abstract:Results are presented to describe the laminar flow patterns around a prolate spheroid at angles of attack of 1, 2, 3, and 30 degrees and complement those obtained previously at 6 degrees. They were obtained by solving threedimensional boundary-layer equations with a combination of standard and characteristic box methods and with a stability criterion to ensure numerical accuracy. Emphasis Is placed on the nature of separation which, In agreement with experiment but contrary to some theoretical claims, is shown to be open for all angles of attack and to be coincident with a particular skin friction line.
Model studies of hydrogen atom addition and abstraction processes involving ortho-, meta-, and para-benzynes.

A. Clark,E. Davidson

DOI: https://doi.org/10.1021/JA0159620

IF: 15

2001-10-04

Journal of the American Chemical Society

Abstract:H-atom addition and abstraction processes involving ortho-, meta-, and para-benzyne have been investigated by multiconfigurational self-consistent field methods. The H(A) + H(B)...H(C) reaction (where r(BC) is adjusted to mimic the appropriate singlet-triplet energy gap) is shown to effectively model H-atom addition to benzyne. The doublet multiconfiguration wave functions are shown to mix the "singlet" and "triplet" valence bond structures of H(B)...H(C) along the reaction coordinate; however, the extent of mixing is dependent on the singlet-triplet energy gap (DeltaE(ST)) of the H(B)...H(C) diradical. Early in the reaction, the ground-state wave function is essentially the "singlet" VB function, yet it gains significant "triplet" VB character along the reaction coordinate that allows H(A)-H(B) bond formation. Conversely, the wave function of the first excited state is predominantly the "triplet" VB configuration early in the reaction coordinate, but gains "singlet" VB character when the H-atom is close to a radical center. As a result, the potential energy surface (PES) for H-atom addition to triplet H(B)...H(C) diradical is repulsive! The H3 model predicts, in agreement with the actual calculations on benzyne, that the singlet diradical electrons are not coupled strongly enough to give rise to an activation barrier associated with C-H bond formation. Moreover, this model predicts that the PES for H-atom addition to triplet benzyne will be characterized by a repulsive curve early in the reaction coordinate, followed by a potential avoided crossing with the (pi)1(sigma*)1 state of the phenyl radical. In contrast to H-atom addition, large activation barriers characterize the abstraction process in both the singlet ground state and first triplet state. In the ground state, this barrier results from the weakly avoided crossing of the dominant VB configurations in the ground-state singlet (S0) and first excited singlet (S1) because of the large energy gap between S0 and S1 early in the reaction coordinate. Because the S1 state is best described as the combination of the triplet X-H bond and the triplet H(B)...H(C) spin couplings, the activation barrier along the S0 abstraction PES will have much less dependence on the DeltaE(ST) of H(B)...H(C) than previously speculated. For similar reasons, the T1 potential surface is quite comparable to the S0 PES.
Effects of 12 weeks of beta-hydroxy-beta-methylbutyrate free acid gel supplementation on muscle mass, strength, and power in resistance trained individuals

KA Dunsmore,Ryan P. Lowery,N. Duncan,G. Davis,J. Rathmacher,SM Baier,EM Sikorski,TJ Morrison,M. Naimo,J. Walters,Stephanie M. C. Wilson,Jacob M. Wilson

DOI: https://doi.org/10.1186/1550-2783-9-S1-P5

2012-11-19

Journal of the International Society of Sports Nutrition

Abstract:
DNA adducts derived from safrole, estragole and related compounds, and from benzene and its metabolites.

D. Phillips

Abstract:
Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy

Yuanjun Wu,Yong Wu,Yanli Ji,Jiajie Liang,Ziyi He,Yanhui Liu,Li Tang,Ganping Guo

DOI: https://doi.org/10.3389/fmed.2021.697192

IF: 3.9

2021-08-12

Frontiers in Medicine

Abstract:There has previously been a report of a patient developing haemolytic anaemia following exposure to cefoperazone. Another case has been reported involving the detection of cefoperazone-dependent antibodies in the absence of immune haemolytic anaemia. To date, no serological evidence has been reported to suggest that cefoperazone can lead to drug-induced immune haemolytic anaemia (DIIHA). This report aims to fill these gaps in knowledge by describing a case of DIIHA caused by cefoperazone-dependent antibodies. A 59-year-old man developed fatal haemolytic anaemia while receiving cefoperazone-tazobactam or cefoperazone-sulbactam for the treatment of a lung infection that occurred after craniocerebral surgery. This eventually led to renal function impairment. Prior to the discontinuation of cefoperazone treatment, the patient showed strong positive (4+) results for both anti-IgG and anti-C3d direct antiglobulin test (DAT), while cefoperazone-dependent IgM and IgG antibodies were detected. The patient's plasma and O-type RBCs were incubated with tazobactam or sulbactam solution at 37°C for 3 h, the results of DAT for anti-IgG and anti-C3d were both positive. Forty-three days after the discontinuation of cefoperazone, the results of DAT for anti-IgG and anti-C3d were negative. Meanwhile incubation of the patient's fresh serum and his own RBCs with cefoperazone at 37°C, gave rise to mild haemolysis, and the results of DAT for both anti-IgG and anti-C3d were positive. It is suggested that cefoperazone-dependent antibodies can activate complement, and the non-immunologic protein adsorption effect of tazobactam or sulbactam can enhance IgG and complement binding to RBCs. This may promote the formation of immunocomplexes and complement activation, thereby aggravating haemolysis.

medicine, general & internal
A Unified DAQ Interconnection Network With Precise Time Synchronization

F. Lemke,David Slogsnat,N. Burkhardt,U. Bruening

DOI: https://doi.org/10.1109/TNS.2010.2042176

IF: 1.703

2010-04-12

IEEE Transactions on Nuclear Science

Abstract:This paper focuses on the interconnection network used as a part of the Data Acquisition System of the Compressed Baryonic Matter experiment at the Facility for Antiproton and Ion Research in Darmstadt, Germany. This experiment will have special demands on the Data Acquisition System like limited space for hardware, radiation tolerance, flexibility for different types of network traffic and support for synchronization mechanisms. The specialty of the CBM network is that it uses only a single bidirectional fiber link for all network abilities and providing a deterministic latency message for precise time synchronisation. This led to the development of a new network and protocol.
Severe piperacillin-tazobactam-induced hemolysis in a cystic fibrosis patient

Andrew D Kerkhoff,Lauren Patrick,Patricia Cornett,Mary-Ellen Kleinhenz,Sam Brondfield

DOI: https://doi.org/10.1002/ccr3.1256

2017-11-02

Abstract:Piperacillin-tazobactam is one of the most common causes of drug-induced immune hemolytic anemia (DIIHA) and is frequently utilized, especially in patients with cystic fibrosis (CF). Here, we report a case of life-threatening piperacillin-tazobactam-associated DIIHA in a 30-year-old woman with CF and propose management recommendations for piperacillin-tazobactam-associated DIIHA in CF patients.
Association of HIV-Infection and Antiretroviral Therapy With Levels of Endothelial Progenitor Cells and Subclinical Atherosclerosis

D. Gómez-Garre,V. Estrada,A. Ortega-Hernández,P. Muñoz-Pacheco,S. Serrano-Villar,M. Ávila,M. Fuentes-Ferrer,T. Tejerina,A. Fernandez-cruz

DOI: https://doi.org/10.1097/QAI.0b013e31826afbfc

2012-12-15

Journal of Acquired Immune Deficiency Syndromes

Abstract:Background:Although in the general population circulating vascular progenitor cell levels have been implicated in the homeostasis of the vascular wall through differentiation into endothelium and/or smooth muscle cells, it has not yet been assessed in HIV-infected patients. We herein investigated the number of progenitor cell subpopulations in HIV-infected patients and its relationship to carotid intima-media thickness (c-IMT). Methods:Blood samples were collected from 200 HIV-infected patients and CD34+/KDR+, CD34+/VE-cadherin+, and CD14+/Endoglin+ progenitor cells were identified by flow cytometry. c-IMT was determined by ultrasonography. A group of 27 healthy subjects was used as control group. Results:In our population (20 ART-naive patients and 180 treated patients), traditional cardiovascular risk factors were not found predictive of vascular progenitor cell levels. However, antiretroviral therapy (ART)-treatment was identified as the main predictive value for low CD34+/KDR+ cells and high CD14+/Endoglin+ cells after adjustment by cardiovascular risk factors (age, sex, hypertension, diabetes, and hyperlipidaemia) and HIV-related characteristics (HIV duration and ART treatment). Low levels of circulating CD34+/KDR+ or CD34+/VE-cadherin+ endothelial progenitor cells tended to be associated with increased c-IMT. However, a positive association was found between CD14+/Endoglin+ cells and c-IMT. Low number of CD34+/KDR+ cells was also associated with the longest exposure to nucleoside reverse transcriptase inhibitors and/or protease inhibitors. Conclusions:ART exposure is the main predictor of circulating vascular progenitor cell levels. However, their levels are only partially associated with high c-IMT in HIV-infected patients. ART has already been found to have proatherogenic effect, but our data first describe its relationship with vascular progenitor cells and c-IMT.
Marked reduction in haemoglobin levels secondary to ceftizoxime-induced immune haemolytic anaemia in diabetic patients

Shengjie Wu,Li Jing,Yipeng Feng,Liping Chen

DOI: https://doi.org/10.1111/jcpt.13135

Abstract:What is known and objective: Drug-induced immune haemolytic anaemia (DIIHA) is rare and difficult to diagnose. In diabetic patients, the diagnosis of DIIHA is even harder. In the current study, we report on two cases of ceftizoxime-induced immune haemolytic anaemia in diabetic patients. Case description: Two diabetic patients (suffering from type 1 and type 2 diabetes mellitus, respectively) presented with rapid reduction in haemoglobin levels when exposed to ceftizoxime (2g q12h). They both achieved symptom improvement after switching to another antibiotic. What is new and conclusion: The persistently reduced haemoglobin levels in diabetic patients may contribute to DIIHA. Reviewing patients' medical records might provide some valuable clues as to the causes of DIIHA.
[NYCTOHEMERAL VARIATIONS OF CARDIAC RATE IN THE DOG AT REST].

P. Duchêne-Marullaz,J. Talvard,J. Vacher

Abstract:
[Drug-induced immune hemolytic anemia caused by cefmetazole]

Natsuki Shioji,Minoru Mizutani,Mariko Okayama,Haruna Katayama,Eiko Ooya,Takao Sekine,Masahiro Masuya

DOI: https://doi.org/10.11406/rinketsu.59.884

Abstract:A 56-year-old female who was diagnosed with acute calculous cholecystitis received intravenous administration of cefmetazole (CMZ) from the day of admission; she underwent laparoscopic cholecystectomy on the 13th hospital day. She was referred to our department because of hematuria that persisted for 3 days and progressive anemia on the day after the surgery. Laboratory data showed the following results: hemoglobin (Hb) level, 6.8 g/dl; reticulocyte count, 3.4%; serum lactate dehydrogenase, 1,505 IU/l; serum creatinine, 1.1 mg/dl; and undetectable haptoglobin. The direct globulin test showed that the patient was positive for IgG. Thus, drug-induced immune hemolytic anemia (DIIHA) was considered. All drugs, including CMZ, were immediately discontinued, and steroid was administered. The signs of hemolysis began to subside 3 days after the initiation of steroid therapy, and the administration of steroid was discontinued on the 5th day of the treatment. The patient's Hb level gradually increased, and the direct globulin test showed that the patient was negative for IgG on the 21st day from the onset of hematuria. Antibodies against CMZ-coated red blood cells were observed in the serum preserved at the onset of hemolysis. DIIHA is a rare but life-threatening disease. Immediate discontinuation of any suspected drugs and the initiation of steroid therapy as necessary are important in cases wherein DIIHA is suspected.
Cefazolin-induced hemolytic anemia in septic arthritis: A case report

S Jawad Zafar,Zachary Wynne,Thomas John,Lauren Groft Buzzalino,Akira A Shishido,David J Riedel

DOI: https://doi.org/10.1016/j.idcr.2024.e02057

2024-08-09

IDCases

Abstract:A 50-year-old woman living with untreated HIV and injection drug use presented with right shoulder pain. The shoulder exam and computed tomography (CT) scan were concerning for septic arthritis. She was started on empiric vancomycin and cefepime and underwent right shoulder debridement and humeral head resection. Bone cultures grew methicillin sensitive Staphylococcus aureus (MSSA); empiric broad-spectrum antibiotics were changed to cefazolin. The patient subsequently developed severe anemia refractory to blood transfusions approximately 6 days later. Further evaluation disclosed hemolytic anemia attributable to cefazolin. Antibiotic therapy was switched from cefazolin to daptomycin, and the patient was started on prednisone. She had sustained improvement in hemoglobin values above 6 g/dL without requiring further transfusions prior to hospital discharge. Drug-induced immune hemolytic anemia from cefazolin is rare but has been reported primarily in the perioperative setting. Here, we present a case following initiation of treatment for septic arthritis.
A RARE CAUSE OF RECURRENT HAEMOLYTIC ANAEMIA: CARBOPLATIN AND PACLITAXEL-INDUCED AUTOIMMUNE HAEMOLYTIC ANAEMIA

Pitchaporn Yingchoncharoen,Jerapas Thongpiya,Shrinkhala Maharjan,Mahmoud Abdelnabi,Samuel Kim,Sakditad Saowapa,Judy Lalmuanpuii

DOI: https://doi.org/10.12890/2023_003740

2023-01-27

Abstract:Drug-induced immune haemolytic anaemia (DIIHA) is a rare but serious complication affecting approximately 1 in 1,000,000 patients, but its incidence might be underestimated due to misdiagnosis. Several factors should be considered to ensure an accurate diagnosis, including previous medical history, comorbidities, drug history, the temporal relationship between drug exposure and symptom onset, haemolytic features, and comorbidities in suspected cases. The authors report a case of DIIHA caused by combination chemotherapy with carboplatin and paclitaxel complicated with haeme pigment-induced acute kidney injury. Learning points: Drug-induced immune haemolytic anaemia (DIIHA) should be suspected in patients with abrupt immune haemolytic anaemia with a temporal relationship between drug exposure and symptom onset.The main management of DIIHA consists of urgent discontinuation of the suspected drug and supportive treatment with close monitoring, resulting in a favourable outcome in most cases; the role of corticosteroids in DIIHA remains unclear.Haeme pigment-induced acute kidney injury is induced by intravascular haemolysis where urinalysis reveals elevated haemoglobin.
Ceftriaxone-induced severe hemolytic anemia, renal calculi, and cholecystolithiasis in a 3-year-old child: a case report and literature review

Enfu Tao,Huangjia Zhou,Meili Zheng,Yisha Zhao,Junfen Zhou,Junhui Yuan,Tianming Yuan,Changhua Zheng

DOI: https://doi.org/10.3389/fphar.2024.1362668

IF: 5.6

2024-03-15

Frontiers in Pharmacology

Abstract:Ceftriaxone is widely used in pediatric outpatient care for its efficacy against respiratory and digestive system infections, yet its increasing association with severe immune hemolytic reactions requires heightened vigilance from pediatricians. This report details a rare and severe case of ceftriaxone-induced severe immune hemolytic anemia (IHA), hemolytic crisis, myocardial injury, liver injury, renal calculi, and cholecystolithiasis in a previously healthy 3-year-old child. The child, treated for bronchitis, experienced sudden pallor, limb stiffness, and altered consciousness following the fifth day of ceftriaxone infusion, with hemoglobin (Hb) levels precipitously dropping to 21 g/L. Immediate cessation of ceftriaxone and the administration of oxygen therapy, blood transfusion, intravenous immunoglobulin (IVIG), and corticosteroids led to a gradual recovery. Despite initial improvements, the patient's condition necessitated extensive hospital care due to complications including myocardial injury, liver injury, renal calculi, and cholecystolithiasis. After a 12-day hospital stay and a 3-month follow-up, the child showed complete normalization of Hb and liver function and resolution of calculi. In children, ceftriaxone infusion may trigger severe, potentially fatal, hemolytic reactions. Pediatricians must promptly recognize symptoms such as pallor, limb stiffness, and unresponsiveness, indicative of ceftriaxone-induced severe IHA, and immediately discontinue the drug. Effective management includes timely blood transfusion, respiratory support, IVIG administration, and corticosteroids when necessary, along with rigorous vital signs monitoring. Continued vigilance is imperative, even after cessation of ceftriaxone, to promptly address any residual adverse effects.

pharmacology & pharmacy

[Specialization in veterinary medicine].

Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report

Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature

Simulation model for wide-area multi-service passive radar coverage predictions

[Surgical repair of secondary local defect after auricular reconstruction].

Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis

Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness

AD-A 201 35 0 Distribution Unlimited

Model studies of hydrogen atom addition and abstraction processes involving ortho-, meta-, and para-benzynes.

Effects of 12 weeks of beta-hydroxy-beta-methylbutyrate free acid gel supplementation on muscle mass, strength, and power in resistance trained individuals

DNA adducts derived from safrole, estragole and related compounds, and from benzene and its metabolites.

Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy

A Unified DAQ Interconnection Network With Precise Time Synchronization

Severe piperacillin-tazobactam-induced hemolysis in a cystic fibrosis patient

Association of HIV-Infection and Antiretroviral Therapy With Levels of Endothelial Progenitor Cells and Subclinical Atherosclerosis

Marked reduction in haemoglobin levels secondary to ceftizoxime-induced immune haemolytic anaemia in diabetic patients

[NYCTOHEMERAL VARIATIONS OF CARDIAC RATE IN THE DOG AT REST].

[Drug-induced immune hemolytic anemia caused by cefmetazole]

Cefazolin-induced hemolytic anemia in septic arthritis: A case report

A RARE CAUSE OF RECURRENT HAEMOLYTIC ANAEMIA: CARBOPLATIN AND PACLITAXEL-INDUCED AUTOIMMUNE HAEMOLYTIC ANAEMIA

Ceftriaxone-induced severe hemolytic anemia, renal calculi, and cholecystolithiasis in a 3-year-old child: a case report and literature review